Picture of Taisho Pharmaceutical Holdings Co logo

4581 — Taisho Pharmaceutical Holdings Co News Story

0.000.00%
jp flag iconLast trade - 00:00
HealthcareBalancedLarge CapHigh Flyer

Table: Taisho Pharmaceutical HD -Q1 group results

Aug 4 (Reuters)- 
             Taisho Pharmaceutical Holdings Co Ltd 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                   3 months ended      3 months ended       Year to 
                  Jun 30, 2023        Jun 30, 2022     Mar 31, 2024 
                     LATEST             YEAR-AGO          LATEST    
                     RESULTS             RESULTS         FORECAST   
  Sales               80.80               69.07           314.50    
                   (+17.0 pct)         (+8.1 pct)       (+4.4 pct)  
  Operating            9.07                5.25            18.50    
                   (+72.7 pct)         (+96.3 pct)      (-19.6 pct) 
  Recurring           11.13                9.25            22.00    
                   (+20.3 pct)        (+129.2 pct)      (-27.7 pct) 
  Net                  4.36                5.75            13.00    
                   (-24.1 pct)        (+387.6 pct)      (-31.6 pct) 
  EPS               53.23 yen           70.16 yen       158.58 yen  
  EPS Diluted       53.15 yen           70.08 yen                   
  Ann Div                              100.00 yen       100.00 yen  
  -Q2 div                               50.00 yen        50.00 yen  
  -Q4 div                               50.00 yen        50.00 yen  
  
  NOTE - Taisho Pharmaceutical Holdings Co Ltd. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4581.T

Recent news on Taisho Pharmaceutical Holdings Co

See all news